Dose-dependent biphasic effects of Eucommia ulmoides extract on growth performance and gut-microbiota-liver axis in largemouth bass ( Micropterus salmoides )

The intensification of largemouth bass aquaculture necessitates safe, efficacious feed additives to replace antibiotics. Eucommia ulmoides extract (EUE) exhibits phytogenic potential, yet its dose-response efficacy and gut-microbiota-mediated mechanisms remain unresolved in this species. A 120-day feeding trial was conducted with 990 juvenile largemouth bass randomly allocated to six dietary treatments: basal diet (control) or basal diet supplemented with EUE at 0.3‰, 0.6‰, 0.9‰, 1.2‰, or 1.5‰. Growth performance, hepatic antioxidant capacity, serum biochemistry, intestinal morphology, and gut microbiota were systematically evaluated. The results showed that the 0.9‰ EUE group achieved optimal outcomes: weight gain increased by 15.7% and FCR decreased by 14.3% compared with the control ( P < 0.05). Histologically, 0.9‰ EUE preserved the most compact hepatic lobular architecture with minimal lipid vacuolization, whereas concentrations ≥ 1.2‰ induced dose-dependent hepatocyte vacuolation and intestinal goblet cell hyperplasia, revealing a biphasic, hormesis-like dose-response. Serum biochemical profiling identified a distinctive “high-flux, high-clearance” metabolic phenotype at 0.9‰, characterized by peak concentrations of HDL, total protein, and cholesterol ( P < 0.05), indicating enhanced reverse cholesterol transport and protein anabolism. Intestinal morphometry demonstrated a “tall-and-dense” absorptive architecture in the 0.9‰ group, with significantly elevated villus height and the highest villus density among all treatments ( P < 0.05). Microbiota analysis revealed that 0.9‰ EUE selectively enriched Clostridium ⁠ ⁠ sensu ⁠ ⁠ stricto _1 (13.61% vs. <0.1% in the control and high-dose groups), a keystone genus implicated in bile acid biotransformation and short-chain fatty acid metabolism, suggesting a gut-microbiota-liver axis as the mechanistic driver. Paradoxically, the highest microbial diversity and richness occurred at 0.3‰, yet this did not translate into improved growth, challenging the prevailing “diversity-equals-health” paradigm in intensive aquaculture systems.

Authors

Institutions

Publication Details

Journal
Israeli Journal of Aquaculture - Bamidgeh
Published
2026-11-06
DOI
https://doi.org/10.46989/001c.172499
Primary Topic
Aquaculture Nutrition and Growth
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Dose-dependent biphasic effects of Eucommia ulmoides extract on growth performance and gut-microbiota-liver axis in largemouth bass ( Micropterus salmoides )

Shufang Gao, Hong Li, Yongtao Tang, Jin Meng et al.
6 links
Israeli Journal of Aquaculture - Bamidgeh
Aquaculture Nutrition and Growth
article

Dose-dependent biphasic effects of Eucommia ulmoides extract on growth performance and gut-microbiota-liver axis in largemouth bass ( Micropterus salmoides )

Shufang Gao, Hong Li, Yongtao Tang, Jin Meng, Yongmou Chen, Guilin Chi, Yuan Tian, Xusheng Guo, Yang Zhou, Yongxu Cheng
article en

Abstract

The intensification of largemouth bass aquaculture necessitates safe, efficacious feed additives to replace antibiotics. Eucommia ulmoides extract (EUE) exhibits phytogenic potential, yet its dose-response efficacy and gut-microbiota-mediated mechanisms remain unresolved in this species. A 120-day feeding trial was conducted with 990 juvenile largemouth bass randomly allocated to six dietary treatments: basal diet (control) or basal diet supplemented with EUE at 0.3‰, 0.6‰, 0.9‰, 1.2‰, or 1.5‰. Growth performance, hepatic antioxidant capacity, serum biochemistry, intestinal morphology, and gut microbiota were systematically evaluated. The results showed that the 0.9‰ EUE group achieved optimal outcomes: weight gain increased by 15.7% and FCR decreased by 14.3% compared with the control ( P < 0.05). Histologically, 0.9‰ EUE preserved the most compact hepatic lobular architecture with minimal lipid vacuolization, whereas concentrations ≥ 1.2‰ induced dose-dependent hepatocyte vacuolation and intestinal goblet cell hyperplasia, revealing a biphasic, hormesis-like dose-response. Serum biochemical profiling identified a distinctive “high-flux, high-clearance” metabolic phenotype at 0.9‰, characterized by peak concentrations of HDL, total protein, and cholesterol ( P < 0.05), indicating enhanced reverse cholesterol transport and protein anabolism. Intestinal morphometry demonstrated a “tall-and-dense” absorptive architecture in the 0.9‰ group, with significantly elevated villus height and the highest villus density among all treatments ( P < 0.05). Microbiota analysis revealed that 0.9‰ EUE selectively enriched Clostridium ⁠ ⁠ sensu ⁠ ⁠ stricto _1 (13.61% vs. <0.1% in the control and high-dose groups), a keystone genus implicated in bile acid biotransformation and short-chain fatty acid metabolism, suggesting a gut-microbiota-liver axis as the mechanistic driver. Paradoxically, the highest microbial diversity and richness occurred at 0.3‰, yet this did not translate into improved growth, challenging the prevailing “diversity-equals-health” paradigm in intensive aquaculture systems.

Israeli Journal of Aquaculture - BamidgehVol. 78(4)
Ningbo University (CN), Xinyang Agriculture and Forestry University (CN)
Good health and well-being
Openalex Percentile: Top 14%
Aquaculture Nutrition and Growth
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon